PREGABALIN LAPL pregabalin 300 mg capsule blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

pregabalin, Quantity: 300 mg

MAH:

Lupin Australia Pty Limited

INN:

Pregabalin

pharmaceutical_form:

Capsule, hard

composition:

Excipient Ingredients: pregelatinised maize starch; purified talc; titanium dioxide; purified water; iron oxide red; Gelatin; sodium lauryl sulfate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide; ethanol absolute

administration_route:

Oral

units_in_package:

20, 60, 14, 56

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Pregabalin LAPL is indicated for the treatment of neuropathic pain in adults. Pregabalin LAPL is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

leaflet_short:

Visual Identification: Size '0' capsules with dark brown cap and white body, imprinted with "PG" on cap and "300" on body in black ink, containing white to off white powder.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

authorization_status:

Licence status A

authorization_date:

2014-12-05